-
公开(公告)号:US20080165030A1
公开(公告)日:2008-07-10
申请号:US11944330
申请日:2007-11-21
申请人: Lun-Chia KUO , Chung-Yi WU , Chung-Chou SHEN , Shih-I HUANG
发明人: Lun-Chia KUO , Chung-Yi WU , Chung-Chou SHEN , Shih-I HUANG
IPC分类号: G08G1/14
摘要: A system configured for parking management in a parking facility, the system comprising a plurality of parking spaces, and a plurality of sensor units corresponding to the plurality of parking spaces, each of the plurality of sensor units being configured to detect a parking status of a corresponding one of the plurality of parking spaces and transmit a first message including the parking status of the corresponding one parking space in a wireless communication network.
摘要翻译: 一种被配置为在停车设施中进行停车管理的系统,所述系统包括多个停车位,以及与所述多个停车位相对应的多个传感器单元,所述多个传感器单元中的每一个被配置为检测所述停车场的停车状态 对应于所述多个停车位中的一个,并且在无线通信网络中发送包括对应的一个停车位的停车状态的第一消息。
-
公开(公告)号:US20160193310A1
公开(公告)日:2016-07-07
申请号:US14392341
申请日:2014-06-26
申请人: Chi-Huey WONG , Chung-Yi WU , Hong-Yang CHUANG , Chien-Tai REN , ACADEMIA SINICA
发明人: Chi-Huey WONG , Chung-Yi WU , Hong-Yang CHUANG , Chien-Tai REN
CPC分类号: A61K39/0011 , A61K31/7028 , A61K39/385 , A61K49/00 , A61K2039/575 , A61K2039/585 , A61K2039/6037 , A61K2039/627 , C07H15/04 , C07H15/10 , C07H15/14 , C07K14/4748
摘要: Described herein are synthetic glycan conjugates, immmunogenic compositions thereof, vaccines thereof, and kits thereof. The present invention further provides methods of using the synthetic glycan conjugates, immunogenic compositions, or vaccines thereof to treat and/or prevent and/or diagnose proliferative diseases such as cancer. The provided glycan conjugate comprises a carrier and a glycan moiety of Formula (I-i) or Formula (I-ii): (structurally represented).
摘要翻译: 本文描述的是合成聚糖缀合物,其免疫原性组合物,其疫苗及其试剂盒。 本发明还提供了使用合成聚糖缀合物,免疫原性组合物或其疫苗来治疗和/或预防和/或诊断增殖性疾病如癌症的方法。 所提供的聚糖缀合物包含式(I-i)或式(I-ii)的载体和聚糖部分:(结构上表示)。
-
3.
公开(公告)号:US20110263828A1
公开(公告)日:2011-10-27
申请号:US12959351
申请日:2010-12-02
申请人: Chi-Huey WONG , Chung-Yi WU
发明人: Chi-Huey WONG , Chung-Yi WU
CPC分类号: C07K16/00 , C07K2317/10 , C07K2317/21 , C07K2317/41 , C12P21/005 , C12Y204/01038 , C12Y204/99 , C12Y302/01051
摘要: Modified Fc regions of antibodies and antibody fragments, both human and humanized, and having enhanced stability and efficacy, are provided. Fc regions with core fucose residues removed, and attached to oligosaccharides comprising terminal sialyl residues, are provided. Antibodies comprising homogeneous glycosylation of Fc regions with specific oligosaccharides are provided. Fc regions conjugated with homogeneous glycoforms of monosaccharides and trisaccharides, are provided. Methods of preparing human antibodies with modified Fc using glycan engineering, are provided.
摘要翻译: 提供人和人源化抗体和抗体片段的修饰的Fc区,并具有增强的稳定性和功效。 提供了核心岩藻糖残基的Fc区,并且连接到包含末端唾液酰残基的寡糖上。 提供了包含具有特异寡糖的Fc区的均相糖基化的抗体。 提供了与单糖和三糖的均匀糖形缀合的Fc区。 提供了使用聚糖工程制备具有修饰的Fc的人抗体的方法。
-
公开(公告)号:US20120195139A1
公开(公告)日:2012-08-02
申请号:US13443619
申请日:2012-04-10
申请人: Hsu-Shun CHEN , Cheng Hung LEE , Chung-Ji LU , Hong-Chen CHENG , Chung-Yi WU , Chih-Chieh CHIU
发明人: Hsu-Shun CHEN , Cheng Hung LEE , Chung-Ji LU , Hong-Chen CHENG , Chung-Yi WU , Chih-Chieh CHIU
CPC分类号: G11C7/1048 , G11C5/14
摘要: In some embodiments related to a memory array, a sense amplifier (SA) uses a first power supply, e.g., voltage VDDA, while other circuitry, e.g., signal output logic, uses a second power supply, e.g., voltage VDDB. Various embodiments place the SA and a pair of transferring devices at a local IO row, and a voltage keeper at the main IO section of the same memory array. The SA, the transferring devices, and the voltage keeper, when appropriate, operate together so that the data logic of the circuitry provided by voltage VDDB is the same as the data logic of the circuitry provided by voltage VDDA.
摘要翻译: 在与存储器阵列相关的一些实施例中,读出放大器(SA)使用第一电源,例如电压VDDA,而其它电路(例如,信号输出逻辑)使用第二电源,例如电压VDDB。 各种实施例将SA和一对传送装置放置在本地IO行上,并将电压保持器放置在同一存储器阵列的主IO部分。 SA,传输装置和电压保持器在适当的情况下一起工作,使得由电压VDDB提供的电路的数据逻辑与由电压VDDA提供的电路的数据逻辑相同。
-
公开(公告)号:US20110090753A1
公开(公告)日:2011-04-21
申请号:US12885826
申请日:2010-09-20
申请人: Cheng Hung LEE , Chung-Yi WU , Hsu-Shun CHEN , Chung-Ji LU
发明人: Cheng Hung LEE , Chung-Yi WU , Hsu-Shun CHEN , Chung-Ji LU
IPC分类号: G11C5/14
CPC分类号: G11C11/413
摘要: An SRAM includes circuitry configured for the SRAM to operate at different operation modes using different voltage levels wherein the voltage level and thus the supply current leakage is regulated based on the operation mode. For example, the SRAM, in a normal operation mode, consumes power as other SRAMs. In a deep sleep mode the supply voltage (e.g., VDDI) for the bit cell in the SRAM macro is lowered by about 20-40% of the SRAM supply voltage (e.g., VDD), sufficient to retain the data in the bit cell. When access to the SRAM is not needed, the SRAM operates in the sleep mode, consuming little or no power.
摘要翻译: SRAM包括被配置用于使用不同的电压电平在不同的操作模式下工作的电路,其中基于操作模式调节电压电平和因此的电流泄漏。 例如,在正常工作模式下,SRAM将作为其他SRAM消耗电力。 在深度睡眠模式下,SRAM宏中的位单元的电源电压(例如,VDDI)降低SRAM电源电压(例如VDD)的约20-40%,足以将数据保留在位单元中。 当不需要访问SRAM时,SRAM在睡眠模式下运行,消耗很少或没有电源。
-
公开(公告)号:US20160175421A1
公开(公告)日:2016-06-23
申请号:US14392333
申请日:2014-06-27
申请人: Chi-Huey WONG , Chung-Yi WU , Chia-Hung WANG , Shiou-Ting LI , ACADEMIA SINICA
发明人: Chi-Huey WONG , Chung-Yi WU , Chia-Hung WANG , Shiou-Ting LI
IPC分类号: A61K39/095 , A61K39/385 , A61K39/39 , C07H15/04
CPC分类号: A61K39/095 , A61K31/715 , A61K39/385 , A61K39/39 , A61K2039/55505 , A61K2039/55511 , A61K2039/55566 , A61K2039/55577 , A61K2039/6037 , A61K2039/627 , C07H1/00 , C07H15/04 , C07H15/18 , C08B37/006
摘要: Described herein are synthetic glycan conjugates comprising a carrier and a glycan moiety derived from Neisseria meningitidis, wherein the glycan moiety is covalently linked to the carrier through a linker. Also provided herein are a mixture of the glycan conjugates thereof, immunogenic compositions thereof, and kits thereof. The invention further provides methods of using the synthetic glycan conjugates and immunogenic compositions thereof to treat and/or reduce the risk of infectious diseases such as bacterial infections.
摘要翻译: 本文描述的是包含载体和衍生自脑膜炎奈瑟氏球菌的聚糖部分的合成聚糖缀合物,其中所述聚糖部分通过连接体共价连接至所述载体。 本文还提供其聚糖缀合物,其免疫原性组合物及其试剂盒的混合物。 本发明还提供使用合成聚糖缀合物及其免疫原性组合物治疗和/或降低感染性疾病如细菌感染的风险的方法。
-
-
-
-
-